East Windsor, NJ (November 16, 2016) –Not all curcuminoid products on the market are the same, according to independent academic researchers at the University of Louisville, Louisville, Kentucky. Their study, Strong Anti-­Inflammatory Effects of Curcumin, was published in the Journal of Nutrition and Health Sciences (JNutrHealthSci16-­‐205 Vetvicka V, University of Louisville, Department of Pathology, Louisville, KY).

 

In a detailed study that involved both in vitro and in vivo models, these researchers compared both anti-­‐inflammatory and anti-­‐oxidant activity, the two premier activities for which Curcuminoids are noted, among five brands on the market. They concluded that Sabinsa’s C3 Complex® was “consistently the most active sample.”

 

The anti-­‐inflammatory comparison involved the study of depression in the expression of the proinflammatory cytokines such as TNF-­‐α, IL-­‐6, IL-­‐10 etc with C3 Complex out in the front. Also C3 Complex® led in reducing acute-­‐inflammation in a xylene-­‐induced acute inflammation of the mouse ear model. Again C3 Complex led the pack in hepatoprotection reflective of the anti-­‐oxidant activity examined in a CCl4 induced hepatic damage in animals leading them to deduce “We can conclude that despite the fact that curcumin truly represents a biologically active natural molecule, its activity differs widely based on the type of sample. Clearly, not all curcumins available were created equal.”

 

“Curcumin is more than just one of Sabinsa’s ingredients; it holds a special place in our hearts and minds because it can significantly enhance human health,” said Shaheen Majeed, Marketing Director, Sabinsa. “Many people here have worked extremely hard to produce the best form of curcumin to deliver health benefits, and are gratified to have their efforts confirmed by independent research. This is more evidence that the specific form of curcumin chosen for a formula is an important decision.”